Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apidra Added to Lantus vs Premixed Insulin in Type 2 Diabetes
NCT01079364Phase 4Terminated
- Sponsor
- Sanofi
- Start
- Jan 2010
- Primary completion
- Jul 2012
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of insulin glulisine in type 2 diabetes mellitus (T2DM), sponsored by Sanofi. Started Jan 2010; status: terminated.
02
Drugs
insulin glulisine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01079364.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01079364.